Author's posts
Responding To The ‘Hidden Pandemic’: Step Forward Life Sciences SMEs
As life returns to something close to normal patterns, the fear is that a rising number of patients will once again be wrongly prescribed antibiotics to treat viral infections – potentially increasing one of the greatest threats to humanity’s health.
Why Is The U.K. Doing So Well At The Vaccine Roll Out?
The brief history of how we got to the point of roll-out so quickly, and its parallels with other areas of the UK’s life sciences industry, holds important lessons for both the sector and policymakers.
